“…This phenotype eventually resolve, resulting in correction of bone growth defects after approximately 4 weeks of age. Vu et al, 1998;Ortega et al, 2003;Nyman et al, 2011;Kojima et al, 2013 Mmp13 −/− Mmp13 −/− (vs. Mmp13 ± ) mice embryos show: (i) progressive changes in the embryonic growth plates (e.g., increased length which persisted in adults), (ii) delayed endochondral ossification, (iii) augmented metaphyseal trabecular bone mass as the mice aged (e.g., 3 months old), (iv) diminished resistance to fracture in long bones, (v) delay in fracture repair, (vi) defective vascular penetration and chondroclast attraction to the fracture callus, (vii) noticeable expression of collagen type X, osteopontin, and VEGF by hypertrophic chondrocytes. Inada et al, 2001;Inada et al, 2002;Inada et al, 2004;Stickens et al, 2004;Kosaki et al, 2007;Tang et al, 2012;Singh et al, 2013 Mmp14 −/− MMP-14 knockout (vs. wild-type) mice show: (i) progressive disturbances (e.g., smaller body size and weight, very high postnatal mortality), possibly caused by deprived feeding and therefore malnutrition, (ii) craniofacial dysmorphism in surviving mice (e.g., short snout, hypertelorism, dome-shaped skull, orbital protrusions, unclosed cranial sutures), (iii) incomplete cartilage remodeling, (iv) impaired formation of secondary ossification centers in the epiphyses, (v) ankylosis resulting from joints with arthritis and other factors (e.g., greater vascularity of the ligaments and tendons, overgrowth of hypercellular and wrongly vascularized synovial tissue), (vi) augmented bone resorption, (vii) osteopenia, (viii) osteoporosis, (ix) dwarfism, (x) mesenchymal stem cells commitment to chondrogenesis and adipogenesis instead of osteogenesis.…”